Study shows ctDNA positivity is the most prognostic factor, demonstrating the potential for Signatera to redefine adjuvant treatment pathways in endometrial cancer This real-world study analyzed 267 ...
Uterine cancer incidence is projected to increase an average of 40.8% between 2018 and 2050, with a bulk of the increase expected to occur among Black women. Mortality rates may almost double, ...
Please provide your email address to receive an email when new articles are posted on . Regardless of age, women with PCOS had an increased risk for endometrial cancer. Women with PCOS aged 45 years ...
A retrospective study found that patients with mismatch repair (MMR)-deficient advanced or recurrent endometrial cancer had numerically longer overall survival (OS) than those with MMR-proficient ...
ALBUQUERQUE, N.M. — A professor at the University of New Mexico Comprehensive Cancer Center has been awarded a 5-year, $12.9 million grant to study endometrial cancer. Dr. Kimberly Leslie is set to ...
Post-hoc analysis evaluating selinexor maintenance therapy in patients with TP53wt endometrial cancer: Progression-free survival by clinical factors in the ENGOT-EN5/GOG-3055/SIENDO study. OS, TTD, ...
Gynecological clear cell cancers (CCCs), very aggressive forms of ovarian and endometrial malignancies, respond poorly to chemotherapy. The low response rates underscore a significant clinical need to ...
Cost-effectiveness of a two-protein panel PMS2/MSH6 for detecting mismatch repair deficiency in endometrial cancer: A single institution study. Single cell characterization of uterine carcinosarcoma ...
Mesothelin-targeted CAR-NKT cells leveraged three recognition mechanisms, potentially limiting antigen escape and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results